Current stages of adjuvant treatment of colon cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/23/suppl_10/x71/6685812/mds354.pdf
Reference31 articles.
1. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma;Moertel;N Engl J Med,1990
2. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer;O'Connell;J Clin Oncol,1998
3. Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-aCT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy;Twelves;ann Oncol,2012
4. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSaIC trial;andré;J Clin Oncol,2009
5. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSaBP C-07 trial, including survival and subset analyses;Yothers;J Clin Oncol,2011
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serum exosomal hsa-circ-0004771 modulates the resistance of colorectal cancer to 5-fluorouracil via regulating miR-653/ZEB2 signaling pathway;Cancer Cell International;2023-10-16
2. Design, synthesis, and evaluation of JTE-013 derivatives as novel potent S1PR2 antagonists for recovering the sensitivity of colorectal cancer to 5-fluorouracil;Bioorganic Chemistry;2023-02
3. Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer;Journal of Medicinal Chemistry;2022-10-21
4. Inhibitory Effect of Chitosan Loaded 5-Fluorouracil Nanoparticles on Colon Cancer in Mice;NANOSCI NANOTECH LET;2020
5. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway;Cancer Letters;2020-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3